Table 1 Baseline patient characteristics.

From: A randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic version

Parameters

Results for entire sample (n = 50)

Results for intervention (n = 25)

Results for control (n = 25)

p-value

Age (years)

31.56 (±5.48)^

32.10 (±5.50)^

31.01 (±5.51)^

0.49+

Gestational age (weeks)

37.21 (1.14)

37.43 (1.29)

37.00 (1.22)

0.75^

BMI (kg/m2)

28.31 (4.28)

28.82 (5.99)

27.34 (4.26)

0.26^

Parity status

Primiparity

20 (40%)

11 (55.0%)

9 (45.0%)

0.56#

Multiparity

30 (60%)

16 (53.30%)

14 (46.70%)

0.56#

AFI level (cm)

13.00 (6.77)

15.00 (8.00)

12.00 (6.35)

0.05^

Placental location

Anterior

7 (18%)

3

4

0.69~

Fundal

30 (75%)

16

14

0.65~

Posterior

3 (7%)

1

2

0.56~

Duration of ECV (s)

530 (749.50)

623 (722.00)

439 (751.50)

0.20^

  1. ^Mean (±SD), Median (IQR), +Independent samples t- test, ^Mann Whitney U test, *statistically significant (p < 0.05), #Chi square test, ~z- test of proportions, BMI- Body Mass Index, ECV- External Cephalic Version, AFI-Amniotic Fluid Index.